RAYSEARCH AT RSNA 2026

29 NOVEMBER – 2 DECEMBER | BOOTH #4951

POWERED BY SOFTWARE

There is a recognized need to standardize thermal ablation techniques and improve local tumor control. Achieving an optimal minimal ablation margin (MAM) is the most relevant factor in influencing local tumor control and it is the only one that is modifiable during the thermal ablation procedure.1 Software-based approaches have been shown to improve the precision of ablation margin evaluation when compared to visual assessments, ultimately enhancing clinical outcomes and promoting consistent, accountable practice across institutions.2
RaySearch’s history of working in close collaboration with leading cancer centers to bring scientific advancements faster to the clinical world helped us bring our image-guided thermal ablation confirmation solution to life. By combining deformable image registration with Deep Learning Segmentation (DLS), our solution delivers state-of-the-art ablation treatments through automated and streamlined workflows.

PROVEN BY OUTCOMES

More than 25 years of innovation – RaySearch’s mission is clear: to provide innovative software that continuously improves cancer treatment and expands possibilities in interventional oncology. Through relentless innovation, close collaboration with leading cancer centers, and a strong focus on research and development, RaySearch empowers medical teams to deliver the highest quality of care. RaySearch’s software is used and trusted by nearly 1,200 clinics in 54 countries, including some of the world's leading cancer centers. 

Optimal ablation margins are essential to achieve local tumor control when leveraging thermal ablation as a therapeutic approach to cancer care. A randomized phase 2 trial1 compared the minimal ablative margin in patients with liver tumors using our advanced image-guided ablation solution versus the margins from traditional visual assessment. Software-based assessment achieved optimal ablation margins in 84% of cases. This translated into a considerable reduction in local tumor progression with 96% of patients treated with the software-based assessment showing no local tumor progression. 

RAYWORLD - COMPREHENSIVE CANCER CARE

For more than 25 years, RaySearch has advanced cancer treatment through software innovation, with solutions used in more than 1,200 clinics worldwide. Now, RaySearch is expanding into interventional and diagnostic radiology to support comprehensive cancer care.

Stop by our booth to talk to our experts and discover more. Highlights of what will be on demonstration include:

  • RaySearch Ablation Confirmation software
  • RayStation®** Deformable Image Registration
  • RayStation®** Deep Learning Segmentation
  • RayStation®** Brachytherapy Planning
  • RaySearch Image Viewer
  • RaySearch Theranostics / Radionuclide Therapy
  • RayStation®** Treatment Planning System
  • RayCare®** Oncology Information System
  • RayIntelligence® Oncology Analytics System

RSNA INNOVATION THEATER PRESENTATION

Sunday 29 November | 1:00 PM

From Radiotherapy Treatment Planning System to Ablation Confirmation: RaySearch Laboratories' software journey toward comprehensive cancer care
Muqeem Qayumm, PhD - Group Manager Service, RaySearch Americas

Join RaySearch Experts as we present how almost three decades of cancer care software development led to a new solution for image-guided ablation, and where that journey goes next.

*Not available for clinical use or commercial sale in the United States.

**RaySearch products and functionalities may be under ongoing development and/or subject to regulatory review and may not be cleared or approved in all jurisdictions. Some products or functionalities described may not be available for clinical use or for sale in the United States or Canada.